The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Epilepsy and Cognitive Impairments in Alzheimer Disease
Open accessAbstract
Alzheimer disease (AD) is associated with cognitive decline and increased incidence of seizures. Seizure activity in AD has been widely interpreted as a secondary process resulting from advanced stages of neurodegeneration, perhaps in combination with other age-related factors. However, recent findings in animal models of AD have challenged this notion, raising the possibility that aberrant excitatory neuronal activity represents a primary upstream mechanism that may contribute to cognitive deficits in these models. The following observations suggest that such activity may play a similar role in humans with AD: (1) patients with sporadic AD have an increased incidence of seizures that appears to be independent of disease stage and highest in cases with early onset; (2) seizures are part of the natural history of many pedigrees with autosomal dominant early-onset AD, including those with mutations in presenilin-1, presenilin-2, or the amyloid precursor protein, or with duplications of wild-type amyloid precursor protein; (3) inheritance of the major known genetic risk factor for AD, apolipoprotein E4, is associated with subclinical epileptiform activity in carriers without dementia; and (4) some cases of episodic amnestic wandering and disorientation in AD are associated with epileptiform activity and can be prevented with antiepileptic drugs. Here we review recent experimental data demonstrating that high levels of beta-amyloid in the brain can cause epileptiform activity and cognitive deficits in transgenic mouse models of AD. We conclude that beta-amyloid peptides may contribute to cognitive decline in AD by eliciting similar aberrant neuronal activity in humans and discuss potential clinical and therapeutic implications of this hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with EOFAD have an 87-fold increased incidence of seizures relative to the age-matched population compared to a threefold increase in seizure incidence in LOAD individuals [6].”
From Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“Hyperexcitability is present in AD brain [142] and epilepsy was shown to promote plaque pathology [110].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Self-citationPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Self-citationAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Cited by
Sorted by citations
Items 401–500 of 675
Mayordomo‐Cava, J., Iborra‐Lázaro, G., Djebari, S., Temprano‐Carazo, S., Sánchez‐Rodríguez, I., Jeremic, D., Gruart, A., Delgado-Garcia, J. M., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2020) · Biology · doi:10.3390/biology9070175 · Cited by 21
Mandell, A. M., & Green, R. C. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch1 · Cited by 22
Do Microglia default on network maintenance in Alzheimer's disease?
Southam, K. A., Vincent, A. J., & Small, D. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151075 · Cited by 20
Geriatric epilepsy: Research and clinical directions for the future
Roberson, E. D., Hope, O. A., Martin, R. C., & Schmidt, D. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.04.005 · Cited by 20
Pyramidal cell axon initial segment in Alzheimer´s disease
Antón‐Fernández, A., León‐Espinosa, G., DeFelipe, J., & Muñoz, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-12700-9 · Cited by 21
An ensemble learning model for continuous cognition assessment based on resting-state EEG
Sun, J., Sun, Y., Shen, A., Li, Y., Gao, X., & Lu, B. (2024) · npj Aging · doi:10.1038/s41514-023-00129-x · Cited by 20
Pinpointing the locus of GABAergic vulnerability in Alzheimer’s disease
Melgosa-Ecenarro, L., Doostdar, N., Radulescu, C. I., Jackson, J., & Barnes, S. J. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.06.017 · Cited by 20
Fu, Y.-H., Lv, R., Jin, L., Lü, Q., Shao, X., He, J., Wu, L., Zhang, L.-S., & Hu, H. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.07.020 · Cited by 20
Vadakkan, K. I. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.042 · Cited by 21
Coelho, D. S., & Moreno, E. (2020) · iScience · doi:10.1016/j.isci.2020.101468 · Cited by 22
Modelling the contributions to hyperexcitability in a mouse model of Alzheimer's disease
Mittag, M., Mediavilla, L., Remy, S., Cuntz, H., & Jedlička, P. (2023) · The Journal of Physiology · doi:10.1113/jp283401 · Cited by 18
AMPA receptors in Alzheimer disease: Pathological changes and potential therapeutic targets
Ning, L., Shen, R., Xie, B., Jiang, Y., Geng, X., & Dong, W. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae093 · Cited by 19
Age- and genotype-related neurophysiologic reactivity to oxidative stress in healthy adults
Пономарева, Н. В., Goltsov, A. Y., Kunijeva, S. S., Scheglova, N. S., Malina, D. D., Алексеевич, М. А., Boikova, T. I., & Rogaev, E. I. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.013 · Cited by 19
A polymorphism in CALHM1 is associated with temporal lobe epilepsy
Lv, R., He, J., Fu, Y.-H., Shao, X., Wu, L., Lu, Q., Jin, L., & Liu, H. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.02.007 · Cited by 19
Pasquini, L., Scherr, M., Tahmasian, M., Myers, N. E., Ortner, M., Kurz, A., Förstl, H., Zimmer, C., Grimmer, T., Akhrif, A., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150823 · Cited by 20
Cortical amyloid burden and age moderate hippocampal activity in cognitively-normal adults
Song, Z., McDonough, I. M., Liu, P., Lu, H., & Park, D. C. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.05.013 · Cited by 19
Koukouli, F., Rooy, M., & Maskos, U. (2016) · Aging · doi:10.18632/aging.101136 · Cited by 21
Blankenship, H. E., Carter, K. A., Pham, K. D., Cassidy, N. T., Markiewicz, A. N., Thellmann, M. I., Sharpe, A. L., Freeman, W. M., & Beckstead, M. J. (2024) · Nature Communications · doi:10.1038/s41467-024-53891-1 · Cited by 18
Experience-Dependent Effects of Muscimol-Induced Hippocampal Excitation on Mnemonic Discrimination
Johnson, S. A., Turner, S. M., Lubke, K. N., Cooper, T. L., Fertal, K. E., Bizon, J. L., Maurer, A. P., & Burke, S. N. (2019) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00072 · Cited by 18
Fu, Y., Li, L., Wang, Y., Chu, G., Kong, X., & Wang, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104542 · Cited by 18
Epileptic Seizures in Alzheimer's Disease: Another Fine MESS?
Larner, A. J., & Marson, A. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102148 · Cited by 18
Giorgi, F. S., Baldacci, F., Dini, E., Tognoni, G., & Bonuccelli, U. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2442-4 · Cited by 17
Sleep/Wake Behavior and EEG Signatures of the TgF344-AD Rat Model at the Prodromal Stage
Kreuzer, M., Keating, G. L., Fenzl, T., Härtner, L., Sinon, C. G., Hajjar, I. M., Ciavatta, V. T., Rye, D. B., & García, P. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239290 · Cited by 17
Joseph, S., Patterson, R., Wang, W., Blumberger, D. M., Rajji, T. K., & Kumar, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210311 · Cited by 17
Beta-Amyloid (Aβ1-42) Increases the Expression of NKCC1 in the Mouse Hippocampus
Lam, P., Vinnakota, C., Guzmán, B. C., Newland, J., Peppercorn, K., Tate, W. P., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2022) · Molecules · doi:10.3390/molecules27082440 · Cited by 17
Romero-García, R., Atienza, M., & Cantero, J. L. (2015) · International Journal of Neural Systems · doi:10.1142/s0129065716500039 · Cited by 17
Granzotto, A., Bomba, M., Castelli, V., Navarra, R., Massetti, N., D’Aurora, M., ONOFRJ, M. C., Cicalini, I., Boccio, P. D., Gatta, V., et al. (2019) · Aging · doi:10.18632/aging.102191 · Cited by 16
Epileptic seizure detection via logarithmic normalized functional values of singular values
Zhou, X., Ling, B. W., Li, C., & Zhao, K. (2020) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2020.102086 · Cited by 16
Liguori, C., Spanetta, M., Romoli, M., Placidi, F., Cesarini, E. N., Mercuri, N. B., & Costa, C. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111434 · Cited by 17
Russo, M. L., Molina-Campos, E., Ybarra, N., Rogalsky, A. E., Musial, T. F., Jiménez, V., Haddad, L. G., Voskobiynyk, Y., D’Souza, G. X., Carballo, G., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.018 · Cited by 16
Alzheimer’s disease and epilepsy: The top 100 cited papers
Zhang, G., Gong, W.-X., Xu, Z.-Y.-R., & Guo, Y. C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.926982 · Cited by 16
Semantic processing and neurobiology in Alzheimer's disease and Mild Cognitive Impairment
Almeida, V. N., & Radanovic, M. (2022) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2022.108337 · Cited by 17
Bazan, N. G. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8897-0 · Cited by 15
Falcicchia, C., Tozzi, F., Gabrielli, M., Amoretti, S., Masini, G., Nardi, G., Guglielmo, S., Ratto, G. M., Arancio, O., Verderio, C., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad170 · Cited by 15
Stephens, G. S., Park, J. K., Eagle, A. L., You, J. C., Silva‐Pérez, M., Fu, C.-H., Choi, S., Romain, C. P. S., Sugimoto, C., Buffington, S. A., et al. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102612 · Cited by 16
Modeling autosomal dominant Alzheimer's disease with machine learning
Luckett, P. H., McCullough, A. A., Gordon, B. A., Strain, J. F., Flores, S. E., Dincer, A., McCarthy, J. E., Kuffner, T. A., Stern, A., Meeker, K. L., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12259 · Cited by 16
Brain injuries can set up an epileptogenic neuronal network
Pototskiy, E., Dellinger, J. R., Bumgarner, S., Patel, J. D., Sherrerd-Smith, W., & Musto, A. E. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.08.003 · Cited by 15
Zhang, X., Xu, L., Yang, S., Hu, L., Dong, F.-Y., Sun, B., & Shen, H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210585 · Cited by 15
Zhou, X., Ling, B. W., Zhou, Y., & Law, N. F. (2023) · Expert Systems with Applications · doi:10.1016/j.eswa.2023.119613 · Cited by 15
Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients
Leitner, D., Kanshin, E., Faustin, A., Thierry, M., Friedman, D. J., Devore, S., Ueberheide, B. M., Devinsky, O., & Wısnıewskı, T. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1221775 · Cited by 17
Multitarget Anti-Alzheimer Hybrid Compounds
Muñoz‐Torrero, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101011-2.00006-4 · Cited by 15
Genetic effect of Type 2 diabetes to the progression of neurological diseasesPreprint
Rahman, M. H., Peng, S., Chen, C., Lió, P., & Moni, M. A. (2018) · doi:10.7287/peerj.preprints.27323v1 · Cited by 15
Пономарева, Н. В., Андреева, Т. В., Protasova, M., Коновалов, Р. Н., Кротенкова, М. В., Kolesnikova, E. P., Malina, D. D., Kanavets, E. V., Алексеевич, М. А., Fokin, V. F., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.931173 · Cited by 14
Reyes, A., Schneider, A. L. C., Kucharska‐Newton, A., Gottesman, R. F., Johnson, E. L., & McDonald, C. R. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1230368 · Cited by 14
Tzavellas, N. P., Tsamis, K. I., Katsenos, A. P., Davri, A. S., Simos, Y. V., Nikas, I. P., Bellos, S., Lekkas, P., Kanellos, F. S., Konitsiotis, S., et al. (2024) · Cells · doi:10.3390/cells13050434 · Cited by 16
Benítez, M. J., Retana, D., Ordóñez‐Gutiérrez, L., Colmena, I., Goméz, M. J., Álvarez, R., Ciorraga, M., Dopazo, A., Wandosell, F. G., & Garrido, J. J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05485-9 · Cited by 17
Tabuena, D. R., Jang, S.-S., Grone, B. P., Yip, O., Jones, E. A. A., Blumenfeld, J. R., Liang, Z., Mann, R. S., Li, Y., Necula, D., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01096-0 · Cited by 17
Shohayeb, B., Ho, U. Y., Hassan, H., Piper, M., & Ng, D. C. H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.549353 · Cited by 14
Treatment of Seizures in Older Patients with Dementia
Cretin, B. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00826-2 · Cited by 14
Serine Racemase Expression Differentiates Aging from Alzheimer’s Brain
Wu, S., Zhou, J., Zhang, H., & Barger, S. W. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220805105106 · Cited by 14
A systematic approach for identifying shared mechanisms in epilepsy and its comorbidities
Hoyt, C. T., Domingo‐Fernándéz, D., Balzer, N. R., Güldenpfennig, A., & Hofmann‐Apitius, M. (2018) · Database · doi:10.1093/database/bay050 · Cited by 14
Wu, Y.-Y., Cheng, I. H.-J., Lee, C.-C., Chiu, M., Lee, M., Chen, T., & Hsu, J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102031 · Cited by 14
Exploring biomarkers of neurodegeneration in epilepsy: Critical insights
Farhan, R., Hashmi, S. A., Kapur, J., D’Abreu, A., Punia, V., Manning, C. A., Smith, V. L., & Zawar, I. (2025) · Epileptic Disorders · doi:10.1002/epd2.70023 · Cited by 14
Optimal Use of Perampanel in Elderly Asian Patients with Epilepsy: Expert Opinion
Huang, C., Boonyapisit, K., Gunadharma, S., Casanova-Gutierrez, J., Jin, L., Nayak, D., & Akamatsu, N. (2022) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s371396 · Cited by 13
Arab, H. H., Eid, A. H., Yahia, R., Alsufyani, S. E., Ashour, A. M., El‐Sheikh, A. A. K., Darwish, H. W., Saad, M. A., Al‐Shorbagy, M. Y., & Masoud, M. A. (2023) · Pharmaceuticals · doi:10.3390/ph16091214 · Cited by 13
State-Dependent Changes in Brain Glycogen Metabolism
DiNuzzo, M., Walls, A. B., Öz, G., Seaquist, E. R., Waagepetersen, H. S., Bak, L. K., Nedergaard, M., & Schousboe, A. (2019) · Advances in neurobiology · doi:10.1007/978-3-030-27480-1_9 · Cited by 13
Cretin, B., Bousiges, O., Hautecloque, G., Philippi, N., Blanc, F., Bitonto, L. D., Martin‐Hunyadi, C., & Sellal, F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.623777 · Cited by 13
Alfaro‐Ruiz, R., Aguado, C., Martín‐Belmonte, A., Moreno‐Martínez, A. E., Merchán‐Rubira, J., Hernández, F., Ávila, J., Fukazawa, Y., & Luján, R. (2022) · Brain Pathology · doi:10.1111/bpa.13115 · Cited by 14
Chronic seizures induce sex-specific cognitive deficits with loss of presenilin 2 function
Knox, K. M., Beckman, M., Smith, C., Jayadev, S., & Barker‐Haliski, M. L. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114321 · Cited by 13
Cavanagh, C., Colby-Milley, J., Farso, M. C., Krantic, S. M., & Quirion, R. (2011) · Future Neurology · doi:10.2217/fnl.11.50 · Cited by 15
Pitkänen, A., & Bolkvadze, T. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0025 · Cited by 13
Nonconvulsive Seizures and Dementia: A Case Report
Campana, C., Assenza, G., Pellegrino, G., Benvenga, A., Assenza, F., Ursini, F., Vernieri, F., & Mario, T. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/690305 · Cited by 13
What Goes Up Must Come Down: Homeostatic Synaptic Plasticity Strategies in Neurological Disease
André, E. A., Forcelli, P. A., & Pak, D. T. S. (2018) · Future Neurology · doi:10.2217/fnl-2017-0028 · Cited by 15
Liang, Y., Liu, X., Qiu, L., & Zhang, S. (2018) · Computational Intelligence and Neuroscience · doi:10.1155/2018/1943565 · Cited by 13
Seizures and Epileptiform Activity in Early Alzheimer Disease: How Hard Should We be Looking?
Spencer, D. C. (2014) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597-14.2.73 · Cited by 12
Walsh, C., Ridler, T., Margetts‐Smith, G., Garrido, M. G., Witton, J., Randall, A. D., & Brown, J. T. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0890-21.2022 · Cited by 12
Epileptic variant in the spectrum of Alzheimer's disease – practical implications
Cretin, B. (2024) · Seizure · doi:10.1016/j.seizure.2024.09.015 · Cited by 12
Left Temporal Lobe Epilepsy Revealing Left Posterior Cortical Atrophy Due to Alzheimer's Disease
Cretin, B., Bitonto, L. D., Blanc, F., & Magnin, É. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141953 · Cited by 12
Degeneration of cholinergic basal forebrain nuclei after focally evoked status epilepticus
Biagioni, F., Gaglione, A., Giorgi, F. S., Bucci, D., Moyanova, S. G., Fusco, A. D., Madonna, M., & Fornai, F. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.019 · Cited by 12
Turón, M., Abraira, L., Cazorla, S., Fonseca, E., Quintana, M., Toledo, M., Salas‐Puig, X., & Santamarina, E. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106443 · Cited by 12
Citraro, R., Leo, A., Tallarico, M., Sciaccaluga, M., & Costa, C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220507020635 · Cited by 12
Babiloni, C., Noce, G., Bonaventura, C. D., Lizio, R., Pascarelli, M. T., Tucci, F., Soricelli, A., Ferri, R., Nobili, F. M., Famà, F., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.514136 · Cited by 12
Joseph, D. J., Liu, C., Peng, J., Liang, G., & Wei, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223509 · Cited by 11
Regulation of Alzheimer's disease-associated proteins during epileptogenesis
von Rüden, E., Zellinger, C., Gedon, J., Walker, A., Bierling, V., Deeg, C. A., Hauck, S. M., & Potschka, H. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.037 · Cited by 11
Eglen, R. M., & Reisine, T. (2018) · SLAS TECHNOLOGY · doi:10.1177/2472630318803277 · Cited by 11
Liu, S., He, Z., Shi, W., & Li, J. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.110070 · Cited by 10
Sohrabpour, A., Sarovic, D., Zetterberg, H., Hämäläinen, M., Baillet, S., & Khan, S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70835 · Cited by 12
Irmen, R. E., Turner, S. M., Snipes, J. A., Schloss, K. H., Wang, X., Williams, H. C., Velmurugan, G. V., Hunt, J. B., Li, J., Sullivan, P. G., et al. (2026) · npj Dementia · doi:10.1038/s44400-025-00054-8 · Cited by 11
Activity-dependent release of phosphorylated human tau from Drosophila neurons in primary culture
Ismael, S., Sindi, G., Colvin, R. A., & Lee, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101108 · Cited by 12
Sha, S., Chaigneau, T., & Krantic, S. M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.04.005 · Cited by 10
Michaud, F., Francavilla, R., Topolnik, D., Iloun, P., Tamboli, S., Calon, F., & Topolnik, L. (2024) · bioRxiv · doi:10.7554/elife.95412 · Cited by 6
Fasulo, L., Brandi, R., Arisi, I., Regina, F. L., Berretta, N., Capsoni, S., D’Onofrio, M., & Cattaneo, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00020 · Cited by 10
Alzheimer’s genetic risk factor Bin1 controls synapse vesicle exo-endocytosis in inhibitory synapses
Barata, M. A., Perdigão, C., Ramalho, J. S., Gomes, E. R., & Almeida, C. G. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116005 · Cited by 9
Nath, S., Buell, A. K., & Barz, B. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp05961d · Cited by 9
A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity
Bonifazi, G., Luchena, C., Gaminde‐Blasco, A., Ortiz-Sanz, C., Capetillo‐Zarate, E., Matute, C., Alberdi, E. M., & Pittà, M. D. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106473 · Cited by 9
Contemporary Approaches to Alzheimer’s Disease and Frontotemporal Dementia
Roberson, E. D. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-744-0_1 · Cited by 9
Accelerated Cognitive Ageing in Epilepsy: A Neuropsychological Evaluation of Cognitive Deterioration
Breuer, L. E. M., Bernas, A., Boon, P., Besseling, R. M. H., Carrette, E., de Louw, A. J. A., & Aldenkamp, A. P. (2018) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acy042 · Cited by 9
Joksimovic, S. M., DiGruccio, M. R., Boscolo, A., Jevtović‐Todorović, V., & Todorovic, S. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01770-y · Cited by 9
Tinston, J. E., Hudson, M. R., Harutyunyan, A., Chen, Z. Z., & Jones, N. C. (2024) · Epilepsia · doi:10.1111/epi.18222 · Cited by 8
Alcantara‐Gonzalez, D., Kennedy, M., Criscuolo, C., Botterill, J. J., & Scharfman, H. E. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01747-1 · Cited by 10
Gasdermins in neurodegeneration: emerging mechanisms and therapeutic targets
Chen, S., Zhang, J., Chen, X., Lai, Z., Zhao, Z., & Wang, S.-B. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08373-7 · Cited by 8
Hasim, H., Salam, S. K. N. M., Rao, P. V., Muthuraju, S., Mustapha, M., & Asari, M. A. (2022) · Biomedical Research and Therapy · doi:10.15419/bmrat.v9i9.766 · Cited by 8
Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer’s disease
Giménez‐Llort, L., Ratia, M., Pérez, B., Camps, P., Muñoz‐Torrero, D., Badı́a, A., & Clos, M. V. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000292 · Cited by 8
Abou-Khalil, B. W. (2010) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2009.01347.x · Cited by 8
Maladie d’Alzheimer, peptide β-amyloïde et synapses
Hémar, A., & Mulle, C. (2011) · médecine/sciences · doi:10.1051/medsci/2011278015 · Cited by 14
Larner, A. J. (2010) · Clinical Medicine · doi:10.7861/clinmedicine.10-4-391 · Cited by 8
de Haan, W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00110 · Cited by 8
Computational Investigation of Amyloid Peptide Channels in Alzheimer’s Disease
Sadegh‐Zadeh, S., & Kambhampati, C. (2018) · J — Multidisciplinary Scientific Journal · doi:10.3390/j2010001 · Cited by 8
Neurophysiological alterations in the nucleus reuniens of a mouse model of Alzheimer's disease
Walsh, D. A., Brown, J. T., & Randall, A. D. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.006 · Cited by 8
Targeting brain connectivity in Alzheimer’s disease with repurposed drugs
Pini, L., Imbimbo, B. P., Griffa, A., Allali, G., & Pomara, N. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.103001 · Cited by 8
Metadata
- Authors
- Palop, J. J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Palop, Jorge J.
- ORCID
- Palop, Jorge J.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-04-01
- Volume
- 66
- Issue
- 4
- Pages
- 435
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC2812914
- OpenAlex
- W2098676436
- Cited by
- 684
- References
- 47
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 47 · 2023: 50 · 2022: 38 · 2021: 46 · 2020: 34 · 2019: 47 · 2018: 33 · 2017: 40 · 2016: 47 · 2015: 42 · 2014: 43 · 2013: 41 · 2012: 39
- FWCI
- 28.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG023501, P50AG023501)
- National Institute of Neurological Disorders and Stroke (R01NS041787, NS041787)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- Alzheimer's disease, epilepsy, cognitive impairment, amyloid-beta, epileptiform activity, presenilin mutations, amyloid precursor protein, APOE ε4, early-onset Alzheimer's disease, transgenic mouse model, antiepileptic drugs
- MeSH terms
- Alzheimer Disease, Amnesia, Animals, Brain, Cognition Disorders, Disease Models, Animal, Electroencephalography, Epilepsy, Genetic Carrier Screening, Hippocampus, Humans, Mice, Transgenic, Nerve Net, Neural Inhibition, Synaptic Transmission, Picrotoxin, Amyloid beta-Peptides, tau Proteins, GABA Antagonists, Dentate Gyrus, Mice, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
